Oxford Cancer Analytics Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
26
- Latest Deal Type
-
2ndary - Private
- Investors
-
23
Oxford Cancer Analytics General Information
Description
Developer of an artificial intelligence-based healthcare platform designed to identify cancers through targeted blood testing. The company's platform cost-effectively and routinely detects cancer materials shed into the blood, analyzing multidimensional liquid biopsy results that include DNA, proteins, epigenetics, epidemiology, and patient medical history, enabling healthcare providers to achieve early cancer detection and curative treatment.
Contact Information
Website
www.oxcan.orgCorporate Office
- BioEscalator, Innovation Building
- Roosevelt Drive
- Oxford OX3 7FZ
- England, United Kingdom
Corporate Office
- BioEscalator, Innovation Building
- Roosevelt Drive
- Oxford OX3 7FZ
- England, United Kingdom
Oxford Cancer Analytics Timeline
Oxford Cancer Analytics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 9. Later Stage VC (Series A) | 27-Nov-2024 | Completed | Generating Revenue | |||
| 8. Accelerator/Incubator | 18-Jul-2024 | Completed | Generating Revenue | |||
| 7. Early Stage VC | 01-Oct-2022 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 01-Jan-2022 | Completed | Generating Revenue | |||
| 5. Seed Round | 06-Sep-2021 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 09-Mar-2021 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Jan-2020 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 1. Accelerator/Incubator | Completed | Generating Revenue |
Oxford Cancer Analytics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| B Shares | ||||||||
| A Ordinary | 31,125 | $0.001278 | $51.12 | $51.12 | 1x | $51.12 | 12.72% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Oxford Cancer Analytics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Oxford Cancer Analytics Patents
Oxford Cancer Analytics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3232042-A1 | A method and system detecting a health abnormality in a liquid biopsy sample | Pending | 15-Sep-2021 | ||
| EP-4402701-A1 | A method and system detecting a health abnormality in a liquid biopsy sample | Pending | 15-Sep-2021 | ||
| GB-202405254-D0 | A method and system detecting a health abnormality in a liquid biopsy sample | Pending | 15-Sep-2021 | ||
| GB-2625689-A | A method and system detecting a health abnormality in a liquid biopsy sample | Pending | 15-Sep-2021 | G16H50/20 |
Oxford Cancer Analytics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Oxford Cancer Analytics Investors (23)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cross Border Impact Ventures | Impact Investing | Minority | ||
| DigitalDx Ventures | Venture Capital | Minority | ||
| Macmillan Cancer Support | Not-For-Profit Venture Capital | Minority | ||
| OKG Capital | Venture Capital | Minority | ||
| We Venture Capital | Corporate Venture Capital | Minority |
Oxford Cancer Analytics FAQs
-
When was Oxford Cancer Analytics founded?
Oxford Cancer Analytics was founded in 2018.
-
Where is Oxford Cancer Analytics headquartered?
Oxford Cancer Analytics is headquartered in Oxford, United Kingdom.
-
What is the size of Oxford Cancer Analytics?
Oxford Cancer Analytics has 26 total employees.
-
What industry is Oxford Cancer Analytics in?
Oxford Cancer Analytics’s primary industry is Diagnostic Equipment.
-
Is Oxford Cancer Analytics a private or public company?
Oxford Cancer Analytics is a Private company.
-
What is Oxford Cancer Analytics’s current revenue?
The current revenue for Oxford Cancer Analytics is .
-
How much funding has Oxford Cancer Analytics raised over time?
Oxford Cancer Analytics has raised $17.3M.
-
Who are Oxford Cancer Analytics’s investors?
Cross Border Impact Ventures, DigitalDx Ventures, Macmillan Cancer Support, OKG Capital, and We Venture Capital are 5 of 23 investors who have invested in Oxford Cancer Analytics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
